Lars Hyldborg Lundstrøm
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Lars Hyldborg Lundstrøm has a total of 268 co-authors. Here are the top co-authors by number of shared publications:
- Kai Henrik Wiborg Lange
Department of Anesthesiology Copenhagen University Hospital—North Zealand Hillerød Denmark
31 shared publications - Anders Kehlet Nørskov
Department of Anaesthesiology Copenhagen University Hospital—North Zealand Hillerød Denmark
21 shared publications - Jørn Wetterslev
Private Office, Tuborg Sundpark, Hellerup, 2900, Denmark
17 shared publications Christian Rothe
Department of Anesthesia and Intensive Care Copenhagen University Hospital ‐ North Zealand Hillerød Denmark
12 shared publications- Mikkel Herold Madsen
Department of Anaesthesiology, Nordsjaellands Hospital, University of Copenhagen, Hillerød, Denmark
8 shared publications Sina Yousef
Department of Anesthesia and Intensive Care Copenhagen University Hospital ‐ North Zealand Hillerød Denmark
7 shared publications
Latest Publications
- Open Access
- 12 November 2026
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 71 (1)
Avoidance Versus Use of Neuromuscular Blocking Agents for Optimising Video Laryngoscopy‐Assisted Tracheal Intubation—A Systematic Review With Meta‐Analysis and Trial Sequential Analysis
Background: Tracheal intubation during anaesthesia carries risks, and difficult intubation can lead to severe complications. Neuromuscular blocking agents (NMBAs) are widely recommended to improve intubation conditions, but they have potential adverse effects. Video laryngoscopy is widely used, yet evidence on the role of NMBAs in this setting is sparse. We aimed to assess whether avoidance versus use of NMBAs affects first‐pass success and intubation conditions during video laryngoscopy in adults. Method: Randomised controlled trials ( RCTs ) comparing avoidance versus use of NMBAs for tracheal intubation in adults during video laryngoscopy were included. The primary outcome was failed first‐pass intubation, as defined by the individual trials. Secondary outcomes were failed intubation, adverse effects ( AEs ) and serious adverse effects ( SAEs ), and acceptable intubation conditions. Furthermore, trial sequential analysis ( TSA ) was undertaken. Results: 9483 records were screened. Eight RCTs (744 participants) met the inclusion criteria. The primary outcome was extractable from seven trials (690 participants). Individual trial estimates showed either no clear effect or an increased risk of failed first‐pass intubation when NMBAs were avoided. We found a statistically non‐significant RR: 1.81 (95% CI: 0.93–3.55, p = 0.08, Cochran's Q = 12.0, p = 0.04, I 2 = 58%, D 2 = 74%, TSA adjusted RR: 1.77, TSA adjusted 95% CI: 0.48–6.50, GRADE = very low certainty of evidence) comparing avoidance versus use of NMBAs. TSA showed that the trial sequential monitoring boundaries were not crossed, and the required information size of 2334 was not achieved. Conclusion: The effect of avoidance of NMBAs for facilitating video laryngoscopy‐assisted tracheal intubation in adult patients is uncertain (very low certainty), and the required information size was not reached. Editorial Comment: This systematic review assessed trial evidence concerning whether or not muscle relaxant use is related to first pass failure in intubation attempts using video laryngoscopy. Evidence to date does not support a clear conclusion on whether avoidance of muscle relaxants in this context is beneficial or not, at least for first pass intubation success, though the evidence has very low certainty for this question.
- 12 November 2026
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 71 (1)
Open AccessAvoidance Versus Use of Neuromuscular Blocking Agents for Optimising Video Laryngoscopy‐Assisted Tracheal Intubation—A Systematic Review With Meta‐Analysis and Trial Sequential Analysis
Background: Tracheal intubation during anaesthesia carries risks, and difficult intubation can lead to severe complications. Neuromuscular blocking agents (NMBAs) are widely recommended to improve intubation conditions, but they have potential adverse effects. Video laryngoscopy is widely used, yet evidence on the role of NMBAs in this setting is sparse. We aimed to assess whether avoidance versus use of NMBAs affects first‐pass success and intubation conditions during video laryngoscopy in adults. Method: Randomised controlled trials ( RCTs ) comparing avoidance versus use of NMBAs for tracheal intubation in adults during video laryngoscopy were included. The primary outcome was failed first‐pass intubation, as defined by the individual trials. Secondary outcomes were failed intubation, adverse effects ( AEs ) and serious adverse effects ( SAEs ), and acceptable intubation conditions. Furthermore, trial sequential analysis ( TSA ) was undertaken. Results: 9483 records were screened. Eight RCTs (744 participants) met the inclusion criteria. The primary outcome was extractable from seven trials (690 participants). Individual trial estimates showed either no clear effect or an increased risk of failed first‐pass intubation when NMBAs were avoided. We found a statistically non‐significant RR: 1.81 (95% CI: 0.93–3.55, p = 0.08, Cochran's Q = 12.0, p = 0.04, I 2 = 58%, D 2 = 74%, TSA adjusted RR: 1.77, TSA adjusted 95% CI: 0.48–6.50, GRADE = very low certainty of evidence) comparing avoidance versus use of NMBAs. TSA showed that the trial sequential monitoring boundaries were not crossed, and the required information size of 2334 was not achieved. Conclusion: The effect of avoidance of NMBAs for facilitating video laryngoscopy‐assisted tracheal intubation in adult patients is uncertain (very low certainty), and the required information size was not reached. Editorial Comment: This systematic review assessed trial evidence concerning whether or not muscle relaxant use is related to first pass failure in intubation attempts using video laryngoscopy. Evidence to date does not support a clear conclusion on whether avoidance of muscle relaxants in this context is beneficial or not, at least for first pass intubation success, though the evidence has very low certainty for this question.
- 6 August 2026
- Published by Wiley in World Journal of Surgery
- Vol. 50 (9) , 2609-2624
Associations Between Time‐To‐Surgery and Postoperative Length of Stay and Complications in Patients With Acute Appendicitis
Introduction: Acute appendicitis is a common surgical emergency. The optimal time‐to‐surgery interval remains debated, as studies reported increased complication risk beyond 12 or 24 hours respectively. We hypothesized that time‐to‐surgery of up to 24 hours after admission was not associated with increased postoperative length of stay (LOS) or complications. Methods: This retrospective observational cohort study included adults and adolescents (≥ 15 years) undergoing laparoscopic appendectomy from January 2017–July 2025 in the Capital and the Zealand Regions of Denmark. Data were extracted from the Electronic Health Record system. The primary exposure was time‐to‐surgery intervals. Primary outcome was postoperative LOS. Secondary outcomes were 30‐day postoperative complications. Subgroup analyses were performed for uncomplicated/complicated appendicitis. All outcomes were evaluated by multivariable regression models adjusted for predefined confounders. Results: Of 25,417 laparoscopic appendectomies, 19,089 met eligibility criteria. Compared with time‐to‐surgery < 8 hours, postoperative LOS was reduced when time‐to‐surgery was 8–16 hours (mean difference −2.29 hours, 95% CI: −3.85 to −0.73) and 16–24 hours (−3.92 hours, 95% CI: −6.05 to −1.78). Compared with time‐to‐surgery < 8 hours, odds of postoperative complications were reduced for time‐to‐surgery up to 24 hours, whereas ≥ 36 hours was associated with increased odds (OR 1.57, 95% CI: 1.13 to 2.18). In complicated appendicitis, time‐to‐surgery 24–36 hours was associated with decreased postoperative LOS (−13.0 hours, 95% CI: −22 to −3.6). Conclusion: Time‐to‐surgery of up to 24 hours was not associated with increased postoperative LOS or complications. In contrast, we observed a protective association driven by complicated appendicitis, potentially reflecting effective clinical triage.
- 6 August 2026
- Published by Wiley in World Journal of Surgery
- Vol. 50 (9) , 2609-2624
Associations Between Time‐To‐Surgery and Postoperative Length of Stay and Complications in Patients With Acute Appendicitis
Introduction: Acute appendicitis is a common surgical emergency. The optimal time‐to‐surgery interval remains debated, as studies reported increased complication risk beyond 12 or 24 hours respectively. We hypothesized that time‐to‐surgery of up to 24 hours after admission was not associated with increased postoperative length of stay (LOS) or complications. Methods: This retrospective observational cohort study included adults and adolescents (≥ 15 years) undergoing laparoscopic appendectomy from January 2017–July 2025 in the Capital and the Zealand Regions of Denmark. Data were extracted from the Electronic Health Record system. The primary exposure was time‐to‐surgery intervals. Primary outcome was postoperative LOS. Secondary outcomes were 30‐day postoperative complications. Subgroup analyses were performed for uncomplicated/complicated appendicitis. All outcomes were evaluated by multivariable regression models adjusted for predefined confounders. Results: Of 25,417 laparoscopic appendectomies, 19,089 met eligibility criteria. Compared with time‐to‐surgery < 8 hours, postoperative LOS was reduced when time‐to‐surgery was 8–16 hours (mean difference −2.29 hours, 95% CI: −3.85 to −0.73) and 16–24 hours (−3.92 hours, 95% CI: −6.05 to −1.78). Compared with time‐to‐surgery < 8 hours, odds of postoperative complications were reduced for time‐to‐surgery up to 24 hours, whereas ≥ 36 hours was associated with increased odds (OR 1.57, 95% CI: 1.13 to 2.18). In complicated appendicitis, time‐to‐surgery 24–36 hours was associated with decreased postoperative LOS (−13.0 hours, 95% CI: −22 to −3.6). Conclusion: Time‐to‐surgery of up to 24 hours was not associated with increased postoperative LOS or complications. In contrast, we observed a protective association driven by complicated appendicitis, potentially reflecting effective clinical triage.
- Open Access
- 25 June 2026
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 70 (7) , e70285
Prognostic Factors for Postoperative Complications. An Aggregate Protocol for 10 Observational Studies From the Danish TRIPLE ‐A Cohort of 1.2 Million Surgeries
Background: Postoperative complications substantially increase morbidity, mortality and healthcare costs. Understanding prognostic factors is essential for risk stratification, targeted prevention strategies, and development of prediction models. Objectives: To identify prognostic factors for 18 major postoperative complications in 10 studied domains using the Danish TRIPLE‐A database: (1) acute postoperative pain, nausea and vomiting, and need for rescue opioids; (2) persistent opioid use; (3) acute kidney injury; (4) venous thromboembolism; (5) staphylococcal surgical site infection and infections requiring antibiotic treatment; (6) three airway management complications; (7) transfusion requirements; (8) delirium; (9) new‐onset postoperative atrial fibrillation; and (10) readmission, reoperation and unplanned ICU admission. Methods: We will conduct 10 retrospective cohort studies using electronic health record data from 1.2 million surgical procedures performed in the Capital and Zealand Regions of Denmark from 2017 to 2025. Each individual complication will be identified via validated combinations of ICD‐10 codes, medication administration, laboratory values, radiology examinations, and free‐text mining of clinical notes. Candidate prognostic factors will be selected a priori based on literature review and clinical expertise, and will encompass patient demographics, comorbidities, surgical characteristics, anaesthetic management, vital parameters and biomarkers. We will estimate adjusted associations between candidate prognostic factors and complications using multivariable logistic regression with LASSO penalisation to reduce overfitting. Effect estimates will be reported as odds ratios with 95% confidence intervals, and the relative contribution of predictors will be assessed by changes in model discrimination (Δ‐AUC). The approach for surgical procedure, calendar year, and hospital site will be determined for each study (adjustment, stratification, or inclusion as candidate predictors). Conclusion: These studies aim to validate established prognostic factors and identify novel ones for major postoperative complications, providing a foundation for the development of individualised perioperative risk stratification models.
- 25 June 2026
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 70 (7) , e70285
Open AccessPrognostic Factors for Postoperative Complications. An Aggregate Protocol for 10 Observational Studies From the Danish TRIPLE ‐A Cohort of 1.2 Million Surgeries
Background: Postoperative complications substantially increase morbidity, mortality and healthcare costs. Understanding prognostic factors is essential for risk stratification, targeted prevention strategies, and development of prediction models. Objectives: To identify prognostic factors for 18 major postoperative complications in 10 studied domains using the Danish TRIPLE‐A database: (1) acute postoperative pain, nausea and vomiting, and need for rescue opioids; (2) persistent opioid use; (3) acute kidney injury; (4) venous thromboembolism; (5) staphylococcal surgical site infection and infections requiring antibiotic treatment; (6) three airway management complications; (7) transfusion requirements; (8) delirium; (9) new‐onset postoperative atrial fibrillation; and (10) readmission, reoperation and unplanned ICU admission. Methods: We will conduct 10 retrospective cohort studies using electronic health record data from 1.2 million surgical procedures performed in the Capital and Zealand Regions of Denmark from 2017 to 2025. Each individual complication will be identified via validated combinations of ICD‐10 codes, medication administration, laboratory values, radiology examinations, and free‐text mining of clinical notes. Candidate prognostic factors will be selected a priori based on literature review and clinical expertise, and will encompass patient demographics, comorbidities, surgical characteristics, anaesthetic management, vital parameters and biomarkers. We will estimate adjusted associations between candidate prognostic factors and complications using multivariable logistic regression with LASSO penalisation to reduce overfitting. Effect estimates will be reported as odds ratios with 95% confidence intervals, and the relative contribution of predictors will be assessed by changes in model discrimination (Δ‐AUC). The approach for surgical procedure, calendar year, and hospital site will be determined for each study (adjustment, stratification, or inclusion as candidate predictors). Conclusion: These studies aim to validate established prognostic factors and identify novel ones for major postoperative complications, providing a foundation for the development of individualised perioperative risk stratification models.
- Open Access
- 16 June 2026
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 70 (6) , e70277
Remifentanil Versus Rocuronium for Optimising Video Laryngoscopy Assisted Tracheal Intubation—The ROCVIDEO Trial Protocol
Background: Routine use of neuromuscular blocking agents (NMBAs) is widely recommended to facilitate tracheal intubation. However, NMBA use is associated with potential adverse effects, including postoperative respiratory complications, intraoperative awareness and anaphylaxis. Bolus remifentanil is an alternative, but evidence supporting its effectiveness on first‐pass success when using video laryngoscopy is sparse. We hypothesise that rocuronium reduces failed first‐pass and the risk of induction‐ or airway‐management‐related complications compared with bolus remifentanil when using a video laryngoscope. Methods: ROCVIDEO is a Danish‐Swedish, blinded, randomised, controlled trial comparing rocuronium (0.6 mg/kg) with remifentanil (4 μg/kg) at anaesthesia induction for facilitating orotracheal intubation using video laryngoscopy. Eligible adult participants (ASA‐class I‐III) undergoing general anaesthesia with video laryngoscopy‐assisted orotracheal intubation will be randomised to rocuronium or remifentanil in a ratio of 1:1. Anaesthesia will be induced with propofol and optional fentanyl or sufentanil. Intubation will be initiated 120 s after administration of trial medicine. The two co‐primary outcomes are: (I) anaesthesia‐related adverse events and (II) failed first‐pass intubation. Secondary outcomes include patient satisfaction, length of stay in the post anaesthesia care unit and serious adverse events. The trial will randomise 2684 participants to be able to detect a 30% relative risk reduction in failed first pass intubation and anaesthesia‐related adverse events, with corresponding power of 80% and 99%, respectively, using a two‐sided α of 0.025. Perspectives: Given the global volume of tracheal intubation, even small differences may have substantial clinical implications. ROCVIDEO will generate high‐quality evidence to inform future guidelines aiming to improve global clinical practice. Status: As of 15 June 2026, the trial has randomised 707 participants across 15 sites. Recruitment is expected to be completed in the third quarter of 2027. Trial Registration: ClinicalTrials.gov : NCT06564857; EUClinicalTrials.eu: 2025‐521405‐40‐01
- 16 June 2026
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 70 (6) , e70277
Open AccessRemifentanil Versus Rocuronium for Optimising Video Laryngoscopy Assisted Tracheal Intubation—The ROCVIDEO Trial Protocol
Background: Routine use of neuromuscular blocking agents (NMBAs) is widely recommended to facilitate tracheal intubation. However, NMBA use is associated with potential adverse effects, including postoperative respiratory complications, intraoperative awareness and anaphylaxis. Bolus remifentanil is an alternative, but evidence supporting its effectiveness on first‐pass success when using video laryngoscopy is sparse. We hypothesise that rocuronium reduces failed first‐pass and the risk of induction‐ or airway‐management‐related complications compared with bolus remifentanil when using a video laryngoscope. Methods: ROCVIDEO is a Danish‐Swedish, blinded, randomised, controlled trial comparing rocuronium (0.6 mg/kg) with remifentanil (4 μg/kg) at anaesthesia induction for facilitating orotracheal intubation using video laryngoscopy. Eligible adult participants (ASA‐class I‐III) undergoing general anaesthesia with video laryngoscopy‐assisted orotracheal intubation will be randomised to rocuronium or remifentanil in a ratio of 1:1. Anaesthesia will be induced with propofol and optional fentanyl or sufentanil. Intubation will be initiated 120 s after administration of trial medicine. The two co‐primary outcomes are: (I) anaesthesia‐related adverse events and (II) failed first‐pass intubation. Secondary outcomes include patient satisfaction, length of stay in the post anaesthesia care unit and serious adverse events. The trial will randomise 2684 participants to be able to detect a 30% relative risk reduction in failed first pass intubation and anaesthesia‐related adverse events, with corresponding power of 80% and 99%, respectively, using a two‐sided α of 0.025. Perspectives: Given the global volume of tracheal intubation, even small differences may have substantial clinical implications. ROCVIDEO will generate high‐quality evidence to inform future guidelines aiming to improve global clinical practice. Status: As of 15 June 2026, the trial has randomised 707 participants across 15 sites. Recruitment is expected to be completed in the third quarter of 2027. Trial Registration: ClinicalTrials.gov : NCT06564857; EUClinicalTrials.eu: 2025‐521405‐40‐01
- 22 May 2026
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
Associations Between Time to Reduction and Complications in Patients With First-Time Total Hip Arthroplasty Dislocation: A Retrospective Cohort Study
BACKGROUND: Total hip arthroplasty (THA) is one of the most frequently performed surgeries worldwide. Approximately 1% to 10% of patients experience one or multiple dislocations of their THA, a painful condition requiring urgent treatment. In Denmark, the usual treatment is closed reduction, typically performed in the operating theater under general anesthesia. However, logistical and clinical challenges can delay treatment in an often frail, elderly population. This study investigated whether time to reduction and type of anesthetics were associated with post-reduction length of stay (LOS) and complications in patients with THA dislocation. We hypothesized that longer time to reduction would be associated with increased post-reduction LOS and complications. METHODS: This retrospective observational cohort study included adults (≥18 years) with a first-time THA dislocation who underwent closed reduction in the operating theater, from 1 January 2017 to 31 January 2025 in the Capital and Zealand Regions of Denmark. Data were extracted from the Electronic Health Record “Sundhedsplatformen.” The primary outcome was post-reduction LOS, assessed using linear regression adjusted for predefined confounders. Secondary outcomes were 90-day all-cause mortality, delirium, readmission, intensive care unit admission, infections, acute kidney injury, and cardiovascular complications. RESULTS: A total of 3494 reductions were included; 86.7% were performed within 12 hours of admission. Increasing time to reduction was associated with longer post-reduction LOS. In the reference group (P < .001), 197 hours at 18–24 hours (95% CI 146–249; P < .001), and 137 hours beyond 24 hours (95% CI 119–154; P < .001). Post-reduction LOS beyond 24 hours was also statistically significantly associated with increased mortality, delirium, and infection. CONCLUSIONS: Most patients underwent closed reduction within 12 hours, without increased risk of complications. Reductions exceeding 12 hours of waiting time were associated with longer post-reduction LOS, even when adjusting for known confounders. Further delays were associated with increased odds of mortality, delirium, and infections. Whether these associations were driven by system delays or patient-related factors remains unclear.
- 22 May 2026
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
Associations Between Time to Reduction and Complications in Patients With First-Time Total Hip Arthroplasty Dislocation: A Retrospective Cohort Study
BACKGROUND: Total hip arthroplasty (THA) is one of the most frequently performed surgeries worldwide. Approximately 1% to 10% of patients experience one or multiple dislocations of their THA, a painful condition requiring urgent treatment. In Denmark, the usual treatment is closed reduction, typically performed in the operating theater under general anesthesia. However, logistical and clinical challenges can delay treatment in an often frail, elderly population. This study investigated whether time to reduction and type of anesthetics were associated with post-reduction length of stay (LOS) and complications in patients with THA dislocation. We hypothesized that longer time to reduction would be associated with increased post-reduction LOS and complications. METHODS: This retrospective observational cohort study included adults (≥18 years) with a first-time THA dislocation who underwent closed reduction in the operating theater, from 1 January 2017 to 31 January 2025 in the Capital and Zealand Regions of Denmark. Data were extracted from the Electronic Health Record “Sundhedsplatformen.” The primary outcome was post-reduction LOS, assessed using linear regression adjusted for predefined confounders. Secondary outcomes were 90-day all-cause mortality, delirium, readmission, intensive care unit admission, infections, acute kidney injury, and cardiovascular complications. RESULTS: A total of 3494 reductions were included; 86.7% were performed within 12 hours of admission. Increasing time to reduction was associated with longer post-reduction LOS. In the reference group (P < .001), 197 hours at 18–24 hours (95% CI 146–249; P < .001), and 137 hours beyond 24 hours (95% CI 119–154; P < .001). Post-reduction LOS beyond 24 hours was also statistically significantly associated with increased mortality, delirium, and infection. CONCLUSIONS: Most patients underwent closed reduction within 12 hours, without increased risk of complications. Reductions exceeding 12 hours of waiting time were associated with longer post-reduction LOS, even when adjusting for known confounders. Further delays were associated with increased odds of mortality, delirium, and infections. Whether these associations were driven by system delays or patient-related factors remains unclear.
- Open Access
- 9 May 2026
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 70 (6) , e70246
Effect of Ultrasound‐Guided Lateral Infraclavicular Brachial Plexus Block With Lidocaine or Ropivacaine for Closed Reduction of Distal Radius Fractures: A Randomized Controlled Noninferiority Trial
Background: Closed reduction of distal radius fractures is painful, and current analgesic strategies may be inadequate. Ultrasound‐guided lateral infraclavicular brachial plexus block may offer complete analgesia and muscle relaxation, potentially improving patient comfort and reduction quality. However, benefits and challenges regarding anesthetic agents for this procedure remain unclear. Methods: In this randomized, controlled, blinded, noninferiority trial, 63 adults with distal radius fractures requiring closed reduction received a lateral infraclavicular block with either 30 mL of ropivacaine 0.5%, lidocaine 1% with epinephrine, or ropivacaine 0.2%. The primary outcome was block success at 45 min, defined as complete sensory and extensive motor block of the radial, musculocutaneous, ulnar, and median nerves. Noninferiority was assessed using a margin of 20%. Exploratory outcomes included sensory and motor block assessments, time to pain relief, block duration, pain during reduction, patient satisfaction, quality of closed reduction, fracture treatments, and safety. Results: Ropivacaine 0.2% was statistically inferior to ropivacaine 0.5% in achieving block success at 45 min (risk ratio (RR) 0.63, 97.5% CI 0.40–0.99). Lidocaine 1% with epinephrine did not meet the predefined noninferiority criteria for block success (RR 0.95, 97.5% CI 0.73–1.22) but did provide comparable analgesia with a shorter block duration. Pain scores during reduction were low across all groups, with a significant decrease in pain from baseline. Patient satisfaction was high in all groups. No significant differences were found in the quality of closed reduction, safety, or fracture treatments. Conclusion: Lateral infraclavicular block with ropivacaine 0.2% failed to demonstrate noninferiority for block success and was statistically inferior to ropivacaine 0.5%. Inferiority testing should be interpreted cautiously within the context of a noninferiority design, although the results suggest reduced effectiveness for distal radius fracture reduction. Lidocaine 1% with epinephrine yielded inconclusive results for noninferiority on block success, but provided a shorter block duration without compromising analgesia, patient satisfaction, or quality of reduction. Trial Registration: ClinicalTrials.gov Identifier NCT06379490 (released April 23, 2024); https://clinicaltrials.gov/study/NCT06379490; EUCT Identifier 2024–510,572–20‐00; https://euclinicaltrials.eu/ctis‐public/view/2024‐510572‐20‐00
- 9 May 2026
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 70 (6) , e70246
Open AccessEffect of Ultrasound‐Guided Lateral Infraclavicular Brachial Plexus Block With Lidocaine or Ropivacaine for Closed Reduction of Distal Radius Fractures: A Randomized Controlled Noninferiority Trial
Background: Closed reduction of distal radius fractures is painful, and current analgesic strategies may be inadequate. Ultrasound‐guided lateral infraclavicular brachial plexus block may offer complete analgesia and muscle relaxation, potentially improving patient comfort and reduction quality. However, benefits and challenges regarding anesthetic agents for this procedure remain unclear. Methods: In this randomized, controlled, blinded, noninferiority trial, 63 adults with distal radius fractures requiring closed reduction received a lateral infraclavicular block with either 30 mL of ropivacaine 0.5%, lidocaine 1% with epinephrine, or ropivacaine 0.2%. The primary outcome was block success at 45 min, defined as complete sensory and extensive motor block of the radial, musculocutaneous, ulnar, and median nerves. Noninferiority was assessed using a margin of 20%. Exploratory outcomes included sensory and motor block assessments, time to pain relief, block duration, pain during reduction, patient satisfaction, quality of closed reduction, fracture treatments, and safety. Results: Ropivacaine 0.2% was statistically inferior to ropivacaine 0.5% in achieving block success at 45 min (risk ratio (RR) 0.63, 97.5% CI 0.40–0.99). Lidocaine 1% with epinephrine did not meet the predefined noninferiority criteria for block success (RR 0.95, 97.5% CI 0.73–1.22) but did provide comparable analgesia with a shorter block duration. Pain scores during reduction were low across all groups, with a significant decrease in pain from baseline. Patient satisfaction was high in all groups. No significant differences were found in the quality of closed reduction, safety, or fracture treatments. Conclusion: Lateral infraclavicular block with ropivacaine 0.2% failed to demonstrate noninferiority for block success and was statistically inferior to ropivacaine 0.5%. Inferiority testing should be interpreted cautiously within the context of a noninferiority design, although the results suggest reduced effectiveness for distal radius fracture reduction. Lidocaine 1% with epinephrine yielded inconclusive results for noninferiority on block success, but provided a shorter block duration without compromising analgesia, patient satisfaction, or quality of reduction. Trial Registration: ClinicalTrials.gov Identifier NCT06379490 (released April 23, 2024); https://clinicaltrials.gov/study/NCT06379490; EUCT Identifier 2024–510,572–20‐00; https://euclinicaltrials.eu/ctis‐public/view/2024‐510572‐20‐00
- Open Access
- 13 March 2026
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 70 (4) , e70200
Neuromuscular Block and Video Laryngoscope to Facilitate Intubation—A Survey of Current Practice in Denmark and Sweden
Background: Neuromuscular blocking agents (NMBA) provide optimal conditions for tracheal intubation. A high dose of opioid can be used as an alternative but may give suboptimal conditions for intubation. The use of a video laryngoscope for intubation might eliminate this potential difference. Methods: A survey examining clinical practice regarding tracheal intubation with and without NMBA and use of video laryngoscopes was conducted in Sweden and Denmark. Results: 1771 out of 3181 (56%) of invited anaesthetists responded. Overall, 1365/1771 (77%) preferred using NMBAs for non‐acute tracheal intubation with a considerably higher NMBA preference in Sweden 1011/1073 (94%) than in Denmark 354/700 (51%). A high proportion of Danish anaesthetists 327/700 (47%) compared to 40/1071 (4%) of Swedish anaesthetists reported primarily using opioids without NMBA. Remifentanil was the preferred opioid (1158/1361 (85%)) for intubation without NMBA. The reasons for using NMBA were improved intubating conditions (948/1771 (54%)), departmental tradition (285/1771 (16%)), adherence to local guidelines (264/1771 (15%)), and adherence to national/international guidelines (143/1771 (8%)). Video laryngoscopes were present in every operating theatre for 349/700 (50%) of Danish anaesthetists and 131/1071 (12%) of Swedish anaesthetists. Video laryngoscopes were easily accessible outside the operating room for 350/700 (50%) of Danish anaesthetists and 940/1071 (88%) of Swedish anaesthetists. Conclusions: NMBA use remains the standard for non‐acute tracheal intubation. However, a substantial number of anaesthetists regularly employ a NMBA‐free approach facilitated by high‐potency opioids and video laryngoscopy, particularly in Denmark. These findings emphasise the need for further research and subsequently updated evidence‐based guidance to support safe and effective intubation practices. Editorial Comment: This study, reporting a survey of anesthesia practitioners in Sweden and Denmark assessed preferences concerning how the respondents would manage a series of case scenarios concerning anesthetic drug choices for facilitation of intubation and employment of video laryngoscopy. Quite a bit of variation for preferences is presented by the responses concerning neuromuscular blockade or not to facilitate intubation.
- 13 March 2026
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 70 (4) , e70200
Open AccessNeuromuscular Block and Video Laryngoscope to Facilitate Intubation—A Survey of Current Practice in Denmark and Sweden
Background: Neuromuscular blocking agents (NMBA) provide optimal conditions for tracheal intubation. A high dose of opioid can be used as an alternative but may give suboptimal conditions for intubation. The use of a video laryngoscope for intubation might eliminate this potential difference. Methods: A survey examining clinical practice regarding tracheal intubation with and without NMBA and use of video laryngoscopes was conducted in Sweden and Denmark. Results: 1771 out of 3181 (56%) of invited anaesthetists responded. Overall, 1365/1771 (77%) preferred using NMBAs for non‐acute tracheal intubation with a considerably higher NMBA preference in Sweden 1011/1073 (94%) than in Denmark 354/700 (51%). A high proportion of Danish anaesthetists 327/700 (47%) compared to 40/1071 (4%) of Swedish anaesthetists reported primarily using opioids without NMBA. Remifentanil was the preferred opioid (1158/1361 (85%)) for intubation without NMBA. The reasons for using NMBA were improved intubating conditions (948/1771 (54%)), departmental tradition (285/1771 (16%)), adherence to local guidelines (264/1771 (15%)), and adherence to national/international guidelines (143/1771 (8%)). Video laryngoscopes were present in every operating theatre for 349/700 (50%) of Danish anaesthetists and 131/1071 (12%) of Swedish anaesthetists. Video laryngoscopes were easily accessible outside the operating room for 350/700 (50%) of Danish anaesthetists and 940/1071 (88%) of Swedish anaesthetists. Conclusions: NMBA use remains the standard for non‐acute tracheal intubation. However, a substantial number of anaesthetists regularly employ a NMBA‐free approach facilitated by high‐potency opioids and video laryngoscopy, particularly in Denmark. These findings emphasise the need for further research and subsequently updated evidence‐based guidance to support safe and effective intubation practices. Editorial Comment: This study, reporting a survey of anesthesia practitioners in Sweden and Denmark assessed preferences concerning how the respondents would manage a series of case scenarios concerning anesthetic drug choices for facilitation of intubation and employment of video laryngoscopy. Quite a bit of variation for preferences is presented by the responses concerning neuromuscular blockade or not to facilitate intubation.
- Open Access
- 26 February 2026
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 70 (4) , e70211
Testing of Pre‐Operative Peripheral Nerve Blocks in Randomised Controlled Trials: A Scoping Review
Background: Peripheral nerve blocks are widely used for anaesthesia in upper and lower limb surgery, but the methods used to assess their success vary substantially. This scoping review examined contemporary research practises and the extent to which trials report on peripheral nerve block evaluation. Methods: A search was conducted on PubMed for randomised controlled trials published between 2014 and 2025 in anaesthesia journals, involving pre‐operative peripheral nerve blocks in adults undergoing limb surgery. Two independent authors screened and extracted data for each trial. Outcomes included the proportion of trials that reported block testing, described test methods, defined successful blocks, and reported success rates. Results: Of 284 trials included, 215 (76%, 95% CI 71%–81%) reported testing blocks, and 210 (74%, 95% CI 69%–79%) described the test methods. Of the 215 trials reporting testing, 204 used sensory assessments (95%, 95% CI 91%–97%) and 157 used motor assessments (73%, 95% CI 67%–79%). Success criteria were defined in 164/284 trials (58%, 95% CI 52%–63%), and the same number reported success rates. In the 164 trials reporting on peripheral nerve block success, the median success rate was 98% (IQR 92%–100%). Conclusion: This scoping review investigated contemporary practise in test methodology reporting in RCTs involving PNBs. We found that although most trials do report testing PNBs, about one in four did not. Furthermore, approximately two in five trials did not define what constituted a successful block or report PNB success rates. Lack of consistent and transparent test methodology poses challenges when comparing trials and performing meta‐analyses, and in translating trial findings into clinical practise. This scoping review exposes a methodological blind spot in regional anaesthesia research. Despite widespread use of peripheral nerve blocks, a substantial proportion of randomised trials fail to report testing methods, success definitions, or handling of failed blocks. Such omissions undermine interpretability, comparability, and clinical translation, and strengthen the case for standardised reporting of regional anaesthesia assessment in future trials.
- 26 February 2026
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 70 (4) , e70211
Open AccessTesting of Pre‐Operative Peripheral Nerve Blocks in Randomised Controlled Trials: A Scoping Review
Background: Peripheral nerve blocks are widely used for anaesthesia in upper and lower limb surgery, but the methods used to assess their success vary substantially. This scoping review examined contemporary research practises and the extent to which trials report on peripheral nerve block evaluation. Methods: A search was conducted on PubMed for randomised controlled trials published between 2014 and 2025 in anaesthesia journals, involving pre‐operative peripheral nerve blocks in adults undergoing limb surgery. Two independent authors screened and extracted data for each trial. Outcomes included the proportion of trials that reported block testing, described test methods, defined successful blocks, and reported success rates. Results: Of 284 trials included, 215 (76%, 95% CI 71%–81%) reported testing blocks, and 210 (74%, 95% CI 69%–79%) described the test methods. Of the 215 trials reporting testing, 204 used sensory assessments (95%, 95% CI 91%–97%) and 157 used motor assessments (73%, 95% CI 67%–79%). Success criteria were defined in 164/284 trials (58%, 95% CI 52%–63%), and the same number reported success rates. In the 164 trials reporting on peripheral nerve block success, the median success rate was 98% (IQR 92%–100%). Conclusion: This scoping review investigated contemporary practise in test methodology reporting in RCTs involving PNBs. We found that although most trials do report testing PNBs, about one in four did not. Furthermore, approximately two in five trials did not define what constituted a successful block or report PNB success rates. Lack of consistent and transparent test methodology poses challenges when comparing trials and performing meta‐analyses, and in translating trial findings into clinical practise. This scoping review exposes a methodological blind spot in regional anaesthesia research. Despite widespread use of peripheral nerve blocks, a substantial proportion of randomised trials fail to report testing methods, success definitions, or handling of failed blocks. Such omissions undermine interpretability, comparability, and clinical translation, and strengthen the case for standardised reporting of regional anaesthesia assessment in future trials.
- Open Access
- 25 January 2026
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 70 (3) , e70189
Anesthetic Strategies for Closed Reduction of Dislocated Total Hip Arthroplasty: A Scoping Review
Background: Total hip arthroplasty (THA) is a frequently performed orthopedic procedure, with dislocation being a common complication, often requiring closed reduction. Anesthetic strategies for this vary, and evidence on the efficacy, safety, and cost‐effectiveness of current strategies is limited. The aim of this review was to synthesize the existing literature on anesthetic strategies for closed reduction of dislocated THA to identify best practice, organizational challenges and potential knowledge gaps. Methods: A scoping review was designed and conducted in accordance with current scoping review guidelines. Following a systematic literature search, two independent authors screened studies for eligibility and extracted data on key outcomes including procedural success, anesthetic techniques, hospital setting, intraprocedural complications, and resource use. Results: Fifty‐seven studies were included with no randomized controlled trials being identified. Case reports, case letters, literature reviews, group interviews, and survey studies were excluded due to risk of selection bias, resulting in 22 remaining studies. Median closed reduction success rate was 81% (IQR 77%–92%) for sedation and 95% (IQR 60%–96%) for general anesthesia. Sedation in the emergency department with propofol had higher reduction success rates than sedation with other drugs. However, inconsistent definitions, variation in the use of anesthetic drugs and dosing, and small sample sizes limited comparability between studies. Time from admission to procedure was 2.25 h (IQR 2.0–2.95) for sedation and 7.6 h (IQR 5.3–9) for general anesthesia. Length of stay was 1.09 days (IQR 0.84–1.31) for sedation and 3 days (IQR 1.3–3.4) for general anesthesia. Complications were infrequently and inconsistently reported. Conclusion: A wide range of anesthetic strategies for reduction of dislocated THA were evaluated, with success rates varying considerably across studies. This review demonstrates a substantial gap in the literature regarding the anesthetic management of closed reduction of dislocated THA. High‐quality evidence is needed to inform and balance patient‐relevant outcomes. Editorial Comment: This scoping review presents an updated exploration of the considerations and alternatives for anesthetic management of cases for closed reduction of hip arthroplasty dislocation and closed reduction.
- 25 January 2026
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 70 (3) , e70189
Open AccessAnesthetic Strategies for Closed Reduction of Dislocated Total Hip Arthroplasty: A Scoping Review
Background: Total hip arthroplasty (THA) is a frequently performed orthopedic procedure, with dislocation being a common complication, often requiring closed reduction. Anesthetic strategies for this vary, and evidence on the efficacy, safety, and cost‐effectiveness of current strategies is limited. The aim of this review was to synthesize the existing literature on anesthetic strategies for closed reduction of dislocated THA to identify best practice, organizational challenges and potential knowledge gaps. Methods: A scoping review was designed and conducted in accordance with current scoping review guidelines. Following a systematic literature search, two independent authors screened studies for eligibility and extracted data on key outcomes including procedural success, anesthetic techniques, hospital setting, intraprocedural complications, and resource use. Results: Fifty‐seven studies were included with no randomized controlled trials being identified. Case reports, case letters, literature reviews, group interviews, and survey studies were excluded due to risk of selection bias, resulting in 22 remaining studies. Median closed reduction success rate was 81% (IQR 77%–92%) for sedation and 95% (IQR 60%–96%) for general anesthesia. Sedation in the emergency department with propofol had higher reduction success rates than sedation with other drugs. However, inconsistent definitions, variation in the use of anesthetic drugs and dosing, and small sample sizes limited comparability between studies. Time from admission to procedure was 2.25 h (IQR 2.0–2.95) for sedation and 7.6 h (IQR 5.3–9) for general anesthesia. Length of stay was 1.09 days (IQR 0.84–1.31) for sedation and 3 days (IQR 1.3–3.4) for general anesthesia. Complications were infrequently and inconsistently reported. Conclusion: A wide range of anesthetic strategies for reduction of dislocated THA were evaluated, with success rates varying considerably across studies. This review demonstrates a substantial gap in the literature regarding the anesthetic management of closed reduction of dislocated THA. High‐quality evidence is needed to inform and balance patient‐relevant outcomes. Editorial Comment: This scoping review presents an updated exploration of the considerations and alternatives for anesthetic management of cases for closed reduction of hip arthroplasty dislocation and closed reduction.